etoposide has been researched along with benzene in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahendra, P; Marcus, RE; Nacheva, E; Richards, EM; Sinclair, P | 1 |
| Baker, RK; Irons, RD; Kroll, DJ; Kurz, EU; Pyatt, DW | 1 |
| Guo, W; Ji, Z; McHale, CM; Smith, MT; Zhang, L | 1 |
| Lehman, CE; Pierce, LC; Thys, RG; Wang, YH | 1 |
4 other study(ies) available for etoposide and benzene
| Article | Year |
|---|---|
t(9;13)(q34;q12) chromosomal translocation persisting 4 years post autologous bone marrow transplantation for secondary AML despite morphological remission.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Benzene; Bone Marrow; Bone Marrow Transplantation; Carmustine; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 9; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid; Male; Melphalan; Myelodysplastic Syndromes; Neoplastic Stem Cells; Occupational Diseases; Occupational Exposure; Pancytopenia; Remission Induction; Solvents; Translocation, Genetic; Transplantation, Homologous | 1996 |
Benzene metabolites antagonize etoposide-stabilized cleavable complexes of DNA topoisomerase IIalpha.
Topics: Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Benzene; Carcinogens; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Antagonism; Drug Stability; Etoposide; Humans; Isoenzymes; Leukemia; Protein Binding; Topoisomerase II Inhibitors | 2001 |
The benzene metabolite, hydroquinone and etoposide both induce endoreduplication in human lymphoblastoid TK6 cells.
Topics: Benzene; Cell Line, Tumor; Chromosomes; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Genomics; Humans; Hydroquinones; Lymphocytes; Metaphase; Mutagenicity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Topoisomerase II Inhibitors | 2009 |
Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells.
Topics: Benzene; Bone Marrow Cells; Chromosome Breakage; Core Binding Factor beta Subunit; Diethylnitrosamine; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Etoposide; Gene Rearrangement; Genome, Human; Hematopoietic Stem Cells; Histone-Lysine N-Methyltransferase; Humans; Leukemia; Myeloid-Lymphoid Leukemia Protein; Primary Cell Culture | 2015 |